Skip to main content
    S

    Shuttle Pharmaceuticals Inc (SHPH)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $4.24
    -0.29 (-6.40%)

    Market Cap: $21.58M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Shuttle Pharmaceuticals Inc (SHPH) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Shuttle Pharmaceuticals are TherapeuticsMD (TXMD), Scynexis (SCYX) and Rockwell Medical (RMTI). By market cap, Shuttle Pharmaceuticals ranks 10th of the 13 companies on this page; Cumberland Pharmaceuticals (CPIX) is the largest at $88.16M.

    Peer Comparison

    SHPH's ROIC of -46.0% is below the peer median of -17.3%, and its revenue growth of 0.0% is above the median of -5.2%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Shuttle Pharmaceuticals (SHPH)$21.58MN/AN/A0.0%-46.0%0.0%0.00%
    TherapeuticsMD Inc (TXMD)$21.64MN/A5.6x-6.6%N/A-8.7%0.00%
    Scynexis Inc (SCYX)$31.95MN/A1.8x-53.5%-16.4%-82.8%0.00%
    Rockwell Medical Inc (RMTI)$27.92MN/A0.4x-7.3%-8.8%10.6%0.00%
    Incannex Healthcare Inc. (IXHL)$24.72MN/AN/A0.0%-18.1%-100.0%0.00%
    Talphera Inc. (TLPH)$47.07MN/AN/A0.0%N/A0.0%0.00%
    China Pharma Holdings Inc (CPHI)$22.29MN/A5.4x-114.3%-8.7%-7.5%0.00%
    InterCure Ltd. (INCR)$49.17MN/AN/A-13.2%N/A23.9%0.00%
    Biofrontera Inc (BFRI)$10.40MN/A0.2x-13.8%-124.6%32.9%0.00%
    InMed Pharmaceuticals Inc (INM)$8.55MN/AN/A0.0%N/A-26.2%0.00%
    Cumberland Pharmaceuticals Inc (CPIX)$88.16MN/A3.1x148.6%N/A-74.0%28.79%
    Universe Pharmaceuticals Inc (UPC)$7.59MN/AN/A-11.0%N/A-1.3%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    Peer median$25.68MN/A2.0x-9.2%-17.3%-5.2%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Shuttle Pharmaceuticals, ranked by how closely their business, size, sector and industry match. The largest group, 11 of the 12, is in Drug Manufacturers - Specialty & Generic; the other one is in Biotechnology.

    CompanyAboutPeers
    TherapeuticsMD Inc (TXMD)Drug Manufacturers - Specialty & Generic
    TherapeuticsMD, Inc. is a women's healthcare company in the United States. The company is headquartered in Boca Raton, Florida.
    TXMD competitors
    Scynexis Inc (SCYX)Drug Manufacturers - Specialty & Generic
    SCYNEXIS, Inc., a biotechnology company, offers therapies for the treatment of yeast infections in the United States.
    SCYX competitors
    Rockwell Medical Inc (RMTI)Drug Manufacturers - Specialty & Generic
    Rockwell Medical, Inc. is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with iron deficiency treatment...
    RMTI competitors
    Incannex Healthcare Inc. (IXHL)Drug Manufacturers - Specialty & Generic
    Incannex Healthcare Limited is engaged in the research, development and sale of medicinal cannabinoid products in Australia.
    IXHL competitors
    Talphera Inc. (TLPH)Drug Manufacturers - Specialty & Generic
    Talphera Inc. is a pioneering biotechnology company dedicated to advancing peptide-based therapies for rare diseases and significant unmet medical needs.
    TLPH competitors
    China Pharma Holdings Inc (CPHI)Drug Manufacturers - Specialty & Generic
    China Pharma Holdings, Inc. develops, manufactures and markets generic and branded pharmaceutical and biochemical products primarily for hospitals and private...
    CPHI competitors
    InterCure Ltd. (INCR)Drug Manufacturers - Specialty & Generic
    Syneos Health, Inc., a contract research organization, provides various clinical development services for the medical device and biopharmaceutical industries...
    Biofrontera Inc (BFRI)Drug Manufacturers - Specialty & Generic
    Biofrontera Inc., a biopharmaceutical company, develops and supplies dermatological products for the treatment of skin conditions in the United States.
    BFRI competitors
    InMed Pharmaceuticals Inc (INM)Drug Manufacturers - Specialty & Generic
    InMed Pharmaceuticals Inc., a clinical-stage pharmaceutical company, researches and develops cannabinoid-based therapies.
    Cumberland Pharmaceuticals Inc (CPIX)Drug Manufacturers - Specialty & Generic
    Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development...
    CPIX competitors
    Universe Pharmaceuticals Inc (UPC)Drug Manufacturers - Specialty & Generic
    Universe Pharmaceuticals INC, a pharmaceutical company, is engaged in the manufacture, marketing...
    Plus Therapeutics Inc (PSTV)Biotechnology
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors

    Frequently Asked Questions About SHPH

    Who are Shuttle Pharmaceuticals' main competitors?

    The companies most similar to Shuttle Pharmaceuticals include TherapeuticsMD (TXMD), Scynexis (SCYX), Rockwell Medical (RMTI), Incannex Healthcare (IXHL) and Talphera (TLPH), listed from the closest match.

    Who is Shuttle Pharmaceuticals' biggest competitor?

    Cumberland Pharmaceuticals (CPIX) is the largest of the similar companies at $88.16M; TherapeuticsMD (TXMD) is the closest match by business profile, size, sector and industry.

    How does SHPH stock compare with its competitors?

    SHPH's net margin is 0.0% against a peer median of -9.2%.

    Which of Shuttle Pharmaceuticals' competitors pays a higher dividend?

    Shuttle Pharmaceuticals pays no dividend. Cumberland Pharmaceuticals (CPIX) has a higher forward dividend yield; Cumberland Pharmaceuticals (CPIX) has the highest at 28.79%.

    Is Shuttle Pharmaceuticals bigger than its competitors?

    No. Shuttle Pharmaceuticals is 10th by market cap among the 13 companies on this page; the largest is Cumberland Pharmaceuticals (CPIX) at $88.16M.